Business
Australia strikes deal for new Covid pill that could be used in treatment by early 2022 – The Guardian Australia
Molnupiravir has been shown to prevent serious illness and death, although it is still in late stage clinical trials
Australia has secured 300,000 courses of molnupiravir, an antiviral capsule to treat Covid-19 that could be in use by early 2022.
The Morrison government has struck a supply agreement with MSD to provide the oral treatment if it is approved by the Therapeutic…
Continue Reading
-
General11 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News18 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
Noosa News23 hours agoResilience features in Sunshine Coast Open House
-
Business19 hours agoBell Potter names the best ASX shares to buy in October